Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Cystatin C and aging success.

Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, Rifkin D, Tracy R, Newman AB, Shlipak MG; Cardiovascular Health Study..

Arch Intern Med. 2008 Jan 28;168(2):147-53. doi: 10.1001/archinternmed.2007.40.

2.

Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.

Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG; Health ABC study..

Am Heart J. 2008 Jan;155(1):62-8. Epub 2007 Oct 24.

PMID:
18082491
3.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
4.

Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study.

Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG.

Kidney Int. 2007 Feb;71(3):239-44. Epub 2006 Dec 20.

5.

Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG.

Arch Intern Med. 2007 Nov 12;167(20):2213-9.

6.

NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):205-14. doi: 10.2215/CJN.04910514. Epub 2015 Jan 20.

7.

Cystatin C concentration as a risk factor for heart failure in older adults.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study..

Ann Intern Med. 2005 Apr 5;142(7):497-505.

PMID:
15809461
8.
9.

Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.

Bibbins-Domingo K, Chertow GM, Fried LF, Odden MC, Newman AB, Kritchevsky SB, Harris TB, Satterfield S, Cummings SR, Shlipak MG.

Arch Intern Med. 2006 Jul 10;166(13):1396-402.

PMID:
16832005
10.

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.

N Engl J Med. 2005 May 19;352(20):2049-60.

11.

Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study.

McManus D, Shlipak M, Ix JH, Ali S, Whooley MA.

Am J Kidney Dis. 2007 Mar;49(3):365-72.

12.

Association of cystatin C and depression in healthy elders: the health, aging and body composition study.

Minev E, Unruh M, Shlipak MG, Simsonick E, Yaffe K, Leak TS, Newman AB, Fried LF; Health ABC Study..

Nephron Clin Pract. 2010;116(3):c241-6. doi: 10.1159/000317205. Epub 2010 Jul 2.

PMID:
20606485
13.

Cystatin C as a risk factor for outcomes in chronic kidney disease.

Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ.

Ann Intern Med. 2007 Jul 3;147(1):19-27.

PMID:
17606957
14.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

15.

Serum cystatin C and the risk of Alzheimer disease in elderly men.

Sundelöf J, Arnlöv J, Ingelsson E, Sundström J, Basu S, Zethelius B, Larsson A, Irizarry MC, Giedraitis V, Rönnemaa E, Degerman-Gunnarsson M, Hyman BT, Basun H, Kilander L, Lannfelt L.

Neurology. 2008 Sep 30;71(14):1072-9. doi: 10.1212/01.wnl.0000326894.40353.93.

16.

Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.

Peralta CA, Lee A, Odden MC, Lopez L, Zeki Al Hazzouri A, Neuhaus J, Haan MN.

J Am Geriatr Soc. 2013 Jan;61(1):90-5. doi: 10.1111/jgs.12040. Epub 2012 Dec 18.

17.

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.

Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF.

J Am Soc Nephrol. 2006 Jan;17(1):254-61. Epub 2005 Nov 2.

18.

Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods.

White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA.

J Am Soc Nephrol. 2005 Dec;16(12):3763-70. Epub 2005 Oct 19.

19.

Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates.

Le Bricon T, Leblanc I, Benlakehal M, Gay-Bellile C, Erlich D, Boudaoud S.

Clin Chem Lab Med. 2005;43(9):953-7.

PMID:
16176176
20.

GFR estimated from cystatin C versus creatinine in children born small for gestational age.

Franco MC, Nishida SK, Sesso R.

Am J Kidney Dis. 2008 Jun;51(6):925-32. doi: 10.1053/j.ajkd.2008.02.305. Epub 2008 May 2.

PMID:
18455848

Supplemental Content

Support Center